Index
S&P 500
Market Cap
13.63B
Enterprise Value
16.50B
Income
-238.46M
Sales
4.00B
Book/sh
59.50
Cash/sh
4.53
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
19700
IPO
Jun 23, 2000
P/E
-
Forward P/E
22.42
PEG
1.99
P/S
3.41
P/B
4.80
P/C
62.97
P/FCF
36.78
EV/EBITDA
19.68
EV/Sales
4.13
Quick Ratio
1.04
Current Ratio
1.35
Debt/Eq
1.07
LT Debt/Eq
1.07
Option/Short
Yes / Yes
EPS (ttm)
-4.85
EPS next Y
12.73
EPS next Q
2.96
EPS this Y
10.11%
EPS next Y
12.49%
EPS next 5Y
11.25%
EPS past 3/5Y
- -
Sales past 3/5Y
0.33% 6.55%
EPS Y/Y TTM
-268.79%
Sales Y/Y TTM
-0.74%
EPS Q/Q
-102.91%
Sales Q/Q
-2.72%
Insider Own
1.12%
Insider Trans
-18.28%
Inst Own
119.94%
Inst Trans
10.66%
ROA
-3.16%
ROE
-7.70%
ROIC
-4.06%
Gross Margin
32.63%
Oper. Margin
13.51%
Profit Margin
-5.96%
SMA20
16.71%
SMA50
28.62%
SMA200
49.52%
Trades
Shs Outstand
47.73M
Shs Float
47.21M
52W High
288.02 -0.88%
52W Low
144.26 97.90%
Volatility
3.70% 3.69%
ATR (14)
10.30
RSI (14)
81.39
Beta
1.41
Rel Volume
0.68
Avg Volume
917.20K
Volume
272,806
Perf Week
7.53%
Perf Month
25.10%
Perf Quarter
75.31%
Perf Half Y
72.01%
Perf YTD
43.12%
Perf Year
84.19%
Perf 3Y
33.12%
Perf 5Y
-30.57%
Perf 10Y
244.30%
Prev Close
284.37
Price
285.49
Change %
0.40%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-06-26 Upgrade JP Morgan
Neutral → Overweight
$310
Jul-20-26 Downgrade CLSA
Outperform → Hold
$219
Jun-17-26 Upgrade Morgan Stanley
Equal-Weight → Overweight
$220
May-29-26 Upgrade CLSA
Hold → Outperform
$219
Apr-14-26 Initiated RBC Capital Mkts
Outperform
$215
Dec-15-25 Upgrade BofA Securities
Neutral → Buy
$225
Nov-17-25 Upgrade Argus
Hold → Buy
Nov-06-25 Upgrade Robert W. Baird
Neutral → Outperform
$199
Oct-06-25 Upgrade William Blair
Mkt Perform → Outperform
Oct-02-25 Upgrade Barclays
Equal Weight → Overweight
$195
Sep-09-25 Upgrade Jefferies
Hold → Buy
$195
Jul-09-25 Upgrade Citigroup
Neutral → Buy
$200
May-23-25 Upgrade Redburn Atlantic
Neutral → Buy
$182
May-14-25 Upgrade TD Cowen
Hold → Buy
$179
May-08-25 Upgrade Evercore ISI
In-line → Outperform
$170
Mar-21-25 Downgrade Goldman
Buy → Neutral
$190 → $170
Mar-04-25 Upgrade Citigroup
Sell → Neutral
$155 → $175
Mar-03-25 Upgrade Redburn Atlantic
Sell → Neutral
$188
Jan-22-25 Downgrade William Blair
Outperform → Mkt Perform
Jan-17-25 Downgrade UBS
Buy → Neutral
$250 → $185
Show Previous Ratings
Aug-06-26 09:48AM
Aug-05-26 05:37PM
05:01PM
04:30PM
04:16PM
(Investor's Business Daily)
07:28AM
Loading…
07:28AM
07:00AM
Jul-29-26 04:52PM
Jul-28-26 04:30PM
Jul-15-26 08:00AM
Jul-13-26 08:00AM
Jul-09-26 04:30PM
Jul-03-26 12:25PM
Jun-24-26 04:30PM
(MarketWatch)
+8.31%
+5.25%
08:05AM
02:18AM
Loading…
02:18AM
Jun-19-26 06:07AM
Jun-18-26 08:00AM
Jun-17-26 09:47AM
09:13AM
May-29-26 09:40AM
May-28-26 04:30PM
May-27-26 04:30PM
May-15-26 04:30PM
May-13-26 08:00AM
May-11-26 08:00AM
May-07-26 08:27PM
07:11AM
07:00AM
Apr-30-26 08:00AM
08:00AM
Loading…
Apr-21-26 08:00AM
Apr-16-26 08:00AM
Apr-14-26 09:53AM
Apr-09-26 04:30PM
Apr-06-26 08:55AM
Mar-10-26 10:30AM
Mar-09-26 11:33PM
Mar-05-26 10:34AM
Mar-02-26 08:00AM
Feb-26-26 06:42AM
(Pharmaceutical Technology)
Feb-25-26 09:06AM
07:00AM
Feb-24-26 02:38PM
09:40AM
Feb-23-26 09:15AM
Feb-20-26 08:03AM
Feb-19-26 10:20PM
12:33AM
Feb-18-26 04:06PM
12:49PM
12:33PM
09:30AM
08:55AM
08:10AM
07:33AM
07:16AM
(Associated Press Finance)
07:01AM
07:00AM
Feb-16-26 10:05PM
09:15AM
Feb-15-26 08:58AM
Feb-13-26 09:39AM
07:01AM
(Private Banker International)
Feb-12-26 02:27PM
Feb-11-26 08:21PM
(Morningstar Research)
-8.42%
10:00AM
Feb-10-26 11:34PM
Feb-08-26 11:01PM
Feb-02-26 07:15AM
Jan-27-26 08:10AM
Jan-21-26 04:30PM
08:00AM
Jan-20-26 11:04AM
11:00AM
Jan-19-26 05:59AM
Jan-15-26 12:00PM
09:42AM
Jan-12-26 04:30PM
08:57AM
Jan-09-26 07:45AM
Jan-08-26 08:00AM
Jan-06-26 12:00PM
09:15AM
Dec-22-25 03:00PM
Dec-18-25 08:36AM
Dec-16-25 05:24AM
Dec-15-25 04:36PM
Dec-11-25 08:00AM
Dec-03-25 04:55PM
Dec-01-25 03:42PM
Nov-24-25 07:56AM
Nov-21-25 03:24AM
Nov-20-25 11:54AM
(Worcester Telegram & Gazette)
Nov-17-25 09:15AM
08:00AM
Nov-16-25 10:37PM
Nov-12-25 12:32AM
Nov-06-25 03:58PM
12:31AM
Nov-05-25 08:15PM
(Morningstar Research)
-5.71%
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
CEO & Director Ms. Birgit Girshick
Corporate Senior VP & Chief Accounting Officer Mr. Michael Gunnar Knell
Corporate Executive Vice President of Corporate Development & Strategy Mr. Joseph W. LaPlume J.D.
Corporate Executive VP & Chief People Officer Ms. Victoria L. Creamer
Corporate Executive VP & CFO Mr. Glenn G. Coleman CPA
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
FOSTER JAMES C Director Aug 10 '26 Option Exercise 179.66 28,733 5,162,171 60,329 Aug 11 04:35 PM FOSTER JAMES C Director Aug 10 '26 Sale 275.00 28,733 7,901,575 31,596 Aug 11 04:35 PM Parisotto Shannon M Officer Aug 11 '26 Proposed Sale 279.66 3,714 1,038,657 Aug 11 04:07 PM Girshick Birgit Officer Aug 11 '26 Proposed Sale 279.90 6,500 1,819,350 Aug 11 04:07 PM Knell Michael Gunnar SVP, Finance and CAO Aug 06 '26 Option Exercise 196.12 2,345 459,909 14,197 Aug 10 04:40 PM Knell Michael Gunnar SVP, Finance and CAO Aug 06 '26 Sale 260.38 6,645 1,730,250 11,852 Aug 10 04:40 PM Creamer Victoria L EVP & Chief People Officer Aug 06 '26 Option Exercise 179.66 4,179 750,799 34,230 Aug 10 04:35 PM Creamer Victoria L EVP & Chief People Officer Aug 06 '26 Sale 259.16 4,179 1,083,030 30,051 Aug 10 04:35 PM FOSTER JAMES C Director Aug 10 '26 Proposed Sale 275.00 28,733 7,901,575 Aug 10 04:29 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Aug 05 '26 Sale 263.00 5,046 1,327,098 4,807 Aug 06 04:49 PM Michael Knell Officer Aug 06 '26 Proposed Sale 260.00 6,645 1,727,700 Aug 06 03:09 PM Victoria Creamer Officer Aug 06 '26 Proposed Sale 260.00 4,179 1,086,540 Aug 06 03:09 PM Parisotto Shannon M Officer Aug 05 '26 Proposed Sale 263.00 5,046 1,327,098 Aug 05 04:02 PM FOSTER JAMES C Director Jun 29 '26 Sale 225.00 75,000 16,875,000 31,596 Jul 01 04:59 PM FOSTER JAMES C Director Jun 29 '26 Proposed Sale 225.00 75,000 16,875,000 Jun 29 04:44 PM LaPlume Joseph W EVP, Corp Strategy & Develop Mar 03 '26 Buy 174.54 25 4,364 27,448 Mar 04 04:39 PM LaPlume Joseph W EVP, Corp Strategy & Develop Aug 22 '25 Sale 163.72 400 65,488 23,716 Jan 20 08:49 AM Joseph LaPlume Officer Aug 22 '25 Proposed Sale 152.50 400 61,000 Aug 22 01:37 PM LaPlume Joseph W EVP, Corp Strategy & Develop Aug 18 '25 Sale 157.60 800 126,080 24,116 Aug 20 04:45 PM WALLMAN RICHARD F Former Director Aug 18 '25 Proposed Sale 152.00 22,500 3,420,000 Aug 18 05:16 PM Joseph LaPlume Officer Aug 18 '25 Proposed Sale 157.00 800 125,600 Aug 18 01:27 PM
